Zobrazeno 1 - 10
of 95
pro vyhledávání: '"U.H. Stenman"'
Publikováno v:
HPB. 22:S373
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa431f7d6da85c361701d0b699feece8
https://doi.org/10.1016/j.hpb.2020.04.409
https://doi.org/10.1016/j.hpb.2020.04.409
Autor:
Teemu J. Murtola, Martti Ala-Opas, Tuomas P. Kilpeläinen, Anssi Auvinen, Paula Kujala, Liisa Määttänen, Teuvo L.J. Tammela, U.H. Stenman
Publikováno v:
British Journal of Cancer
Background: There is evidence that prostate cancer (PC) screening with prostate-specific antigen (PSA) serum test decreases PC mortality, but screening has adverse effects, such as a high false-positive (FP) rate. We investigated the proportion of FP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::950fa436e344bfcf82e36769233af2f9
http://europepmc.org/articles/PMC2822946
http://europepmc.org/articles/PMC2822946
Autor:
Matti Hakama, Harri Juusela, Liisa Määttänen, Mirja Ruutu, Martti Ala-Opas, Teuvo L.J. Tammela, Anssi Auvinen, U.H. Stenman, Paula M. Martikainen
Publikováno v:
British Journal of Cancer
Specificity constitutes a component of validity for a screening test. The number of false-positive (FP) results has been regarded as one of major shortcomings in prostate cancer screening. We estimated the specificity of serum prostate-specific antig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a21b3fdb6a414cfac385c6a661b5742a
https://doi.org/10.1038/sj.bjc.6603522
https://doi.org/10.1038/sj.bjc.6603522
Autor:
Paer Stattin, Herman Adlercreutz, Rudolph Kaaks, Torbjörn K. Nilsson, Per Åman, A Nordin, U.H. Stenman, Jie-Xian Zhang, Göran Hallmans, Eva Lundin, Annika Bylund, Anders Bergh
Publikováno v:
European Journal of Cancer Prevention. 12:407-415
The short-term effects of rye bran bread intake in prostate cancer were investigated. Ten men with conservatively treated prostate cancer were randomised to a daily supplement of 295 g of rye bran bread and eight men to 275 g of wheat bread (control)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c83701c769c5ff136a11bc646769d27
https://doi.org/10.1097/00008469-200310000-00010
https://doi.org/10.1097/00008469-200310000-00010
Autor:
Annekatrin Lukanova, Tommy Olsson, Rudolph Kaaks, U.H. Stenman, Elio Riboli, Paer Stattin, Carine Biessy, Stefan Söderberg, S. Rinaldi, Göran Hallmans
Publikováno v:
European Journal of Cancer Prevention. 12:309-315
Despite strong indirect evidence that androgens stimulate prostate cancer development, data from most analytical studies on this association have been negative. To further investigate this issue, we studied the interrelationships between androgenicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8023ad4ad16407c6da4594dfb95538dc
https://doi.org/10.1097/00008469-200308000-00011
https://doi.org/10.1097/00008469-200308000-00011
Autor:
Anssi Auvinen, Teemu J. Murtola, Teuvo L.J. Tammela, U.H. Stenman, Kirsi Talala, A. Vettenranta, K. Taari
Publikováno v:
European Urology Supplements. 16:e424
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7c07b6ea4f582d3a7228b57824b1ae6
https://doi.org/10.1016/s1569-9056(17)30308-1
https://doi.org/10.1016/s1569-9056(17)30308-1
Autor:
U.H. Stenman, Teuvo L.J. Tammela, Liisa Määttänen, Kimmo Taari, Teemu J. Murtola, Thea Veitonmäki, Anssi Auvinen
Publikováno v:
British Journal of Cancer
Background: The association between nonsteroidal antiinflammatory drugs (NSAIDs) and prostate cancer risk remains controversial. We examined the risk among NSAID users in 78 615 men in the Finnish Prostate Cancer Screening Trial. Methods: We obtained
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d162ac577c1780f0e70065679bb8e1e0
https://pubmed.ncbi.nlm.nih.gov/25010865
https://pubmed.ncbi.nlm.nih.gov/25010865
Autor:
Marshfield D. Reding, Detroit R. Demers, Helsinki A. Auvinen, Rotterdam R. Kranse, Alabama A. Oberman, Rotterdam P. Beensterboer, Florence R. Bonardi, Cardiff A. Turkes, Rotterdam F.H. Schröder, Bethesda J. Gohagan, Bethesda N. Simpson, Rotterdam M.A. Dijk, Pittsburgh J.L. Weissfeld, Bethesda P.C. Prorok, Rotterdam J.W.B.W. Rietbergen, Goteborg J. Hugosson, Helsinki L. Teppo, Goteburg G. Aus, Washington E.P. Gellman, Toronto A.B. Miller, Tampere M. Hakama, Quebec B. Candas, Minneapolis J. Mandel, Florence S. Ciatto, Brussels B. Stadaert, Madrid A.B. Sanchez, Madrid A. Paez, St. Louis G.L. Andriole, Lisbon E.C. da Silva, Rotterdam W.I. Kirkels, Antwerp V. Nelen, Rotterdam H.J. de Koning, Lisbon F. Figueiredo, Salt Lake City S. Buys, Rotterdam B.G. Blijenberg, Leeds P.H. Smith, Lund H. Lilja, Antwerp L. Denis, Denver E.D. Crawford, Helsinki U.H. Stenman, Helsinki L. Määttänen, Rotterdam Th.H. van der Kwast, Lisbon H. Monteiro, Antwerp D.B. Rose
Publikováno v:
European Journal of Cancer. 35:262-271
Screening for prostate cancer has been advocated by a number of organisations largely because there is good evidence that administration of the test for prostate specific antigen (PSA) results in the detection of cancers at an early stage. However, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae71f5dd6a71eb361d184e57a8ddf452
https://doi.org/10.1016/s0959-8049(98)00379-7
https://doi.org/10.1016/s0959-8049(98)00379-7
Publikováno v:
The Lancet. 344:1594-1598
Prostate cancer can be detected at an early, potentially curable stage by screening based on digital rectal examination and serum prostate specific antigen (PSA). The value of screening appears doubtful, based on high 10-year survival rates in select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c1a507e1eb441307bd7c34502ed8164
https://doi.org/10.1016/s0140-6736(94)90405-7
https://doi.org/10.1016/s0140-6736(94)90405-7
Autor:
Martin Johansson, Bengt Glimelius, Karin Jirström, Alexander Gaber, Fredrik Pontén, Hakon Birgisson, Kristina Hotakainen, Anders Bjartell, U.H. Stenman
Publikováno v:
British Journal of Cancer
Increased expression of tumour-associated trypsin inhibitor (TATI) in tumour tissue and/or serum has been associated with poor survival in various cancer forms. Moreover, a proinvasive function of TATI has been shown in colon cancer cell lines. In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::484fb0fd6a517ac9ff8a9bbcce03587e
https://pubmed.ncbi.nlm.nih.gov/19384300
https://pubmed.ncbi.nlm.nih.gov/19384300